Diving Medicine has earned a worldwide reputation as the definitive source on diving safety and the management of diving-related health conditions. The new 4th Edition has been completely revised and updated while still retaining its practical clinical orientation. It covers basic diving physiology the pathophysiology of decompression sickness assessment of physical fitness for diving diagnosis and treatment of diving-related disorders and much more. Discusses special considerations for female, elderly, and pediatric divers Covers diving-related problems in people with pre-existing medical conditions, such as pulmonary, cardiac, and neurologic disease Includes information about marine toxicology New chapters on Kinetics of Inert Gas, Marine Poisoning and Intoxication, and Diabetes and Diving Completely revised chapters on Medical Evaluation for Sport Diving Medical Evaluation for Commercial Diving and Medical Evaluation for Military Diving The latest protocols for managing decompression accidents, drowning, and hypothermia

This book aims to be a complete guide to diagnose, manage and treat rare lung diseases encountered by practising pulmonologists and trainees. It extensively covers the "more common" of the rare lung diseases, categorising them based on developmental lung anomalies in adults, airway disorders, diffuse parenchymal lung diseases, neoplasms, rare vascular disorders and other miscellaneous conditions. This comprehensive review facilitates the study and understanding of this complex and diverse set of disorders, focussing on differential diagnosis, evidence-based discussions of management algorithms, and thoughtful analysis of treatment options. Key Features: 1. Reviews multiple rare lung diseases, including ones acquired congenitally to be expressed in old age. 2. Enriched with case studies and illustrations, guides the respiratory physicians and trainees to devise an effective treatment plan. 3. Focuses on concerned investigations, with a section on role of new procedures in the management.

The Understanding Asthma chart takes a look at the causes, symptoms, risk factors and treatments for asthma. The anatomy of airways and gas exchange is graphically depicted, along with a peak flow chart. Images of normal and asthmatic bronchioles are shown for comparison in the asthma attack section. Heavy cover stock with protective varnish for durability.

Get a quick, expert overview of the etiology, diagnosis, and management of pulmonary and extra pulmonary sarcoidosis with this concise, practical resource. Drs. Robert B. Baughman and Dominique Valeyre fully cover the recent advances in various aspects of this disease, including new genetic studies and new diagnostic techniques. It's an ideal resource for pulmonologists and respiratory medicine specialists, as well as primary care physicians and pulmonary/respiratory care nurses. Provides a comprehensive discussion of the various facets of sarcoidosis, including common manifestations of the lung, skin, and eyes, as well as other important aspects such as cardiac and neurologic disease. Covers newer diagnostic techniques for the lungs and elsewhere in the body, each discussed in detail and compared to older diagnostic techniques. Discusses treatment options including anti-inflammatory drugs, and management of other aspects of the disease, such as pulmonary hypertension, fatigue, and small fiber neuropathy. Consolidates today's available information and experience in this important area into one convenient resource.

This issue of Clinics in Chest Medicine, edited by Dr. Michael Niederman, focuses on Pneumonia, with topics including: Inflammation and Pneumonia; The Lung Microbiome's Role in Pneumonia; Biomarkers for the Management of Pneumonia; Influenza and Viral Pneumonia; Guidelines to Manage Community-Acquired Pneumonia (CAP); Vaccines to Prevent CAP; Adjunctive Therapies for CAP; Healthcare Associated Pneumonia; Rapid Diagnostic Methods for Pneumonia; Airway Devices in VAP Pathogenesis and Prevention; Management of VAP; Distinguishing Ventilator-Associated Tracheobronchitis from VAP; Practical Approaches to VAP Prevention; Optimizing Antibiotic Administration for Pneumonia; New Antibiotics for Pneumonia; and Personalized Approach to Pneumonia Management.

Normal and Pathological Bronchial Semiology: A Visual Approach provides normal endobronchial aspects, including variations, anomalies and abnormal findings. Comprehensive coverage includes preoperative airway assessment in lung surgeries, airways after surgery, including complications, process and management, and airway complications in lung transplantation patients. It is a full reference that is perfect for pulmonary researchers, chest physicians, bronchoscopists, pulmonologists and cardiothoracic surgeons.

This issue of Clinics in Chest Medicine, edited by Drs. Peter Marshall and Wassim Fares, focuses on Pulmonary Embolism, with topics including: Clinical Probability Tools for DVT, PE, & Bleeding; Prevention of DVTs and Pulmonary Emboli: General Measures and High-Risk Populations; Diagnosis of DVTs and PEs: New Imaging Tools and Modalities; Perfusion Defects Misdiagnosed as Pulmonary Emboli; The Vicious Cycle of Hypercoagulability and Pulmonary Hypertension; VTE in Special Populations; Preganncy and Thrombo-embolic Disease; Challenges and Changes to the Management of PE in the Emergency Department; The Value of Bedside Echocardiogram in the Setting of Acute & Chronic Pulmonary Embolism; Management of Low-Risk PE; Update on the 'Novel' and Direct Oral Anticoagulants; Risk Stratification: Definitive/Aggressive Treatment of Hemodynamically Stable but Intermediate Risk Patients; Pulmonary Embolism Response Team (PERT); Surgical and Other Interventions for DVTs; IVC Filters; Catheter-Based Therapies of Pulmonary Emboli; Surgical-Based Therapies for PEs; and Chronic Thrombo-embolic Pulmonary Hypertension (CTEPH).

Continuing the Respiratory Pharmacology and Pharmacotherapy series, this volume explores the pathophysiology and therapy of rhinitis. The volume is introduced by a chapter describing the normal anatomy and physiology of the nose and sinuses. Against this background the contributing authors describe and discuss the immunological and pathological changes which occur in rhinitis. The various causes and the types of rhinitis - such as allergic, vasomotor, and infectious - are discussed as are the treatments available (pharmacotherapy, immunotherapy, surgery). The book concludes with a description of the animal models of rhinitis which are now available. This book will be of interest to bench scientists and clinicians alike.

Designed with the practicing clinician in mind, Idiopathic Pulmonary Fibrosis provides a succinct, easy-to-digest overview of this challenging condition in which the cause of thickening lung tissue is unknown. This concise resource by Drs. Kevin K. Brown and Jeff Swigris provides essential information for the physician who sees pulmonary fibrosis patients, including epidemiology, genetics and biomarkers, pathology, diagnosis, disease monitoring, and therapeutics intended to improve the patient's lifespan and quality of life. Covers the process of making the diagnosis of idiopathic pulmonary fibrosis, as well as IPF look-alikes: uncharacterized PF, CTD-ILD, and cHP. Details today's available therapeutics, including Rx, rehabilitation, O2, Tx, and treating comorbidities: OSA, GERD, and PH. Consolidates today's available information on this timely topic into one convenient resource.

-SARS has received much attention and coverage by the media and has a high impact on the public making this a hot research topic for scientists.

-

This issue of Chest Medicine Clinics focuses on Interventional Pulmonology, with topics including: Flexible bronchoscopy; Radiology for mediastinal lymph node station in lung cancer diagnosis and staging; Lung cancer screening; Early lung cancer detection; Palliative care and interventional pulmonology; Anesthesia for flexible and rigid bronchoscopy; Mediastinal and pulmonary pathology: Specimen collection and processing; Bronchial Thermoplasty: A nonpharmacological therapy for severe asthma; Bronchoscopic lung volume reduction; Malignant pleural effusion: From diagnostics to therapeutics; Intrapleural therapeutics; Percutaneous dilational tracheostomy; Tracheobronchial stenosis and Tracheobroncho malacia: diagnostic and therapeutic dilemmas; Pediatric interventional pulmonology; The Business of Bronchoscopy: How to set up an Interventional Pulmonology Program; Bronchoscopic therapies for peripheral lung malignancies; and Bronchial Thermoplasty: A nonpharmacological therapy for severe asthma.

A concise review of the epidemiology, pathogenesis, and management of common respiratory conditions seen in a primary care setting. Using an illuminating case-based approach, Dr. Mintz assesses the key clinical questions that a primary care physician would ask and applies the most up-to-date research and guidelines to offer the practitioner evidence-based solutions. The author covers the range of knowledge needed to provide excellent care for patients with respiratory disease, from the basics of pulmonary function testing to understanding and caring for common respiratory illnesses, including chronic obstructive pulmonary disease, asthma, allergic rhinitis, and pneumonia. For each disorder, Dr. Mintz explains the key points regarding the epidemiology of the disease, its pathophysiology, the differential diagnosis and diagnosis, and its recommended treatment. A special PDA version of Disorders of the Respiratory Tract: Common Challenges in Primary Care is also available.

This issue of Clinics in Chest Medicine focuses on Pulmonary Considerations in Solid Organ and Hematopoietic Stem Cell Transplantation. Editors Vivek Ahya and Joshua Diamond have assembled an expert team of authors on topics such as: Overview of HSCT Transplantation and future directions in treatment of hematologic malignancies; Early Pulmonary complications of HSCT and Prognosis of Respiratory FailureLate Pulmonary complications of HSCT; Overview of Lung Transplantation, Heart-lung transplantation, Lung-Liver transplantation and combined HSCT and lung transplantation; Primary graft dysfunction after Lung Transplantation; Extracorporeal life support (ECLS) in lung transplantation; Evaluation and Management of the potential lung donor (including EVLP); Acute rejection & antibody mediated rejection in lung transplantation; Chronic lung allograft dysfunction (CLAD); Airway complications in lung transplantation; PTLD in solid organ and HSCT transplantation; Respiratory Bacterial and Mycobacterial Infections in solid organ transplantation and HSCT; Respiratory Viral infections in solid organ transplantation and HSCT; Respiratory Fungal infections in solid organ and hematopoietic stem cell transplantation; Non-infectious pulmonary complications of Liver, Heart and Kidney Transplantation; Hepatopulmonary syndrome and portal- pulmonary hypertension in liver failure; implications for liver transplantation.

Diagnostic imaging is an essential component in the evaluation of the patient with known or suspected respiratory tract disease. While chest radiography continues to serve as the primary tool for imaging the chest, advances in computed tomography (CT) have led to a variety of applications such as high-resolution CT (HRCT), advanced 3-D airway imaging, and image-guided procedures. The aim of this book is to deliver a clinically-oriented approach to pulmonary imaging. Each chapter of the book will provide an organized approach to the different facets of imaging of specific clinical scenarios, focusing on strengths and weaknesses of available imaging tests. High quality examples of typical imaging findings of specific conditions will supplement the text. The target readers include practicing internists, pulmonologists, thoracic surgeons, and primary care practitioners. Other readers will include respiratory care therapists and medical students. The proposed cohort of authors represents experts in the field of thoracic radiology. These authors have experience in thoracic radiology and medical writing, each will deliver a high-quality chapter meeting the aims and scope of this book while addressing the target audience. Aside from the first three chapters, which are introductory materials, each author will be invited to select a clinician with whom they work closely to serve as a co-author in order to provide a chapter that maintains the clinical orientation of this book.

This issue of Clinics in Chest Medicine focuses on Pulmonary Complications of Non-Pulmonary Malignancy. Editors Guang-Shing Cheng and Jennifer Possick have assembled an expert team of authors on topics such as: Pulmonary manifestations of non-pulmonary solid malgnancies; Pulmonary manifestations of leukemia and lymphoma; Radiation pneumonitis; Toxicities from conventional chemotherapy; Toxicities from novel targeted therapies; Bacterial pneumonia; Fungal pneumonia; Viral pneumonia; IPS and other early onset non-infectious pulmonary syndromes; Pulmonary GVHD and other late-onset non-infectious pulmonary syndromes; Pulmonary function and pre-transplant risk assessment; Diagnostic Evaluation of Pulmonary Abnormalities in Hematologic Malignancy and HCT; Acute respiratory failure in patients with non-pulmonary malignancy; Critical care prognosis and outcomes in patients with non-pulmonary malignancy; and Palliative and end-of-life care.

Clinically focused and designed to provide a to-the-point overview, Interstitial Lung Disease, by Drs. Talmadge King, Harold Collard, and Luca Richeldi, bring you up to date with increased understanding, new treatment protocols, and recent advances in the field. Written by contributing specialists who are global experts in their respective areas, this one-stop reference provides pulmonologists, intensivists, internal medicine physicians, and researchers with a dependable source of information on current treatment options and patient care. . Evidence for current treatment options for interstitial pneumonia, idiopathic pulmonary fibrosis, and smoking-related interstitial lung diseases. . Approach to diagnosis of interstitial lung diseases, such as sarcoidosis, hypersensitivity pneumonitis, and Churg-Strauss syndrome. . Genetic markers for inherited interstitial lung diseases such as dyskeratosis congenita, tuberous sclerosis/LAM, and hyper-IgE syndrome. . Expert ConsultT eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.

Dr. Goldsworthy has created a state-of-the-art issue that emphasizes the nurse's role in mechanical ventilation. Pertinent clinical topics include the following: basics of mechanical ventilation for nurses; current modes for mechanical ventilation; best practices for managing pain, sedation, and delirium in the mechanically ventilated patient; mobilization of and optimal oxygenation for the mechanicaly ventilated patient; managing complications; and effective weaning strategies. Authors also address mechanical ventilation in both children and neonates. The current content in this issue will leave nurses with the clinical information they need to effectively manage mechanically ventilated patients.

This issue of Sleep Medicine Clinics, guest-edited by Dr. Jessie Bakker, focuses on Unraveling the Puzzle of Adherence in Sleep Medicine. This issue is one of four selected each year by series Consulting Editors, Dr. Teofilo Lee-Chiong and Dr. Ana C Krieger. Articles include: What can we consider to be a clinically meaningful target for PAP adherence?, Adherence to sleep therapies in children and adolescents, Socioeconomic Disparities in Positive Airway Pressure Adherence: An Integrative Review, What do we know about adherence to oral appliances?, Alternative care pathways for OSA and the impact on PAP adherence, Summary and Update on Behavioural Interventions for Improving Adherence with Positive Airway Pressure Treatment in Adults and more.

This issue of Clinics in Chest Medicine focuses on Advances in Mechanical Ventilation. Articles include: Mechanical Ventilation Design Features; Assessing Respiratory System Mechanical Function; Ventilator Induced Lung Injury; Managing Acute Lung Injury; Patient-Ventilator Interactions; Extracorporeal Gas Exchange; Preventing Ventilator Associated Infections; Ventilator Discontinuation Process; Ventilator Management of the Non-injured Lung; Non-invasive Ventilation; and more!

Preterm birth interrupts the normal developmental progression of most organs, particularly when birth occurs at the lowest level of viability. An immediate task is to successfully transition to a post-natal life without a placental circulation. To do this demands careful management of the cardiorespiratory systems. To best help the fragile preterm infant at this demanding time, care-givers must remember two most pressing goals. These are first to maintain adequacy of gas exchange and delivery, while simultaneously minimizing any secondary injury to the fragile preterm lung. However, after these immediate priorities in the delivery room, the longer term effects of an immature lung development and its associated problems come to the forefront. These problems include the inflammation of perinatal infection, oxygen, and invasive mechanical ventilation. Both the immaturity itself, and secondary lung injury and its inflammation - collectively will often lead to the condition termed bronchopulmonary dysplasia (BPD). Although many of these infants may eventually be discharged to home without a need for oxygen supplementation or pulmonary medications, the long-term impact of interrupted lung development and secondary lung injury remain serious concerns. It is now well recognized that mechanical ventilation is pivotal to developing secondary lung injury and BPD. Consequently, a great deal of time and effort has been put into the development and application of non-invasive ventilator (NIV) approaches to supporting respiratory function in neonates. Since the landmark publication by Gregory and colleagues in 1967, nasal continuous positive airway pressure (nCPAP) has been the most commonly applied approach to NIV. This approach has been supported by the recent generation of randomized controlled trials. However, cumulatively these trials have shown only a small reduction in rates of BPD. Outside of the trial data, despite the wider application of nCPAP, rates of BPD remain relatively unchanged over recent years. This has led to investigations of other NIV approaches including nasal ventilation and high flow nasal cannula therapy. Not only have available modes increased, but so have the interfaces through which these modes may be applied. In the issue of Clinic in Perinatology, readers will find an up-to-date review of non-invasive approaches to supporting preterm respiratory function. This draws on the expertise of leading investigators in the field. This issue reviews the physiologic mechanisms by which the various approaches to NIV may support respiratory function; the evidence base supporting different NIV approaches; and adjunctive aspects of NIV therapy including their use during neonatal transport and the application of other supportive therapies such as inhaled NO.

This issue of Immunology and Allergy Clinics, guest edited by Dr. Andrew A. White, is devoted to Aspirin-Exacerbated Respiratory Disease. Articles in this issue include: An Overview of Non-Steroidal Anti-inflammatory Drug Reactions; The Clinical Presentation of Aspirin-Exacerbated Respiratory Disease; Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease; Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis; Pathogenesis of Aspirin Reactions in Aspirin-Exacerbated Respiratory Disease; Performing Aspirin Desensitization; Clinical Trials in Aspirin-Exacerbated Respiratory Disease Treatment; Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease; Mechanisms of Benefit with Aspirin Therapy; Lipid Mediators in Aspirin-Exacerbated Respiratory Disease; and Epigenetic and Genetic Components of Aspirin-Exacerbated Respiratory Disease.

Alcohol Use Disorders and the Lung: A Clinical and Pathophysiological Approach is an excellent resource for clinicians who care for individuals affected by alcohol use disorders in diverse settings. Although alcohol abuse alone does not cause acute lung injury, it renders the lung susceptible to dysfunction in response to the inflammatory stresses of sepsis, trauma, and other clinical conditions recognized to cause acute lung injury. In parallel, these same pathophysiological effects of alcohol abuse significantly increase the risk of a wide range of serious lung infections. Many clinicians involved in the primary treatment of alcohol use disorders, such as addiction psychiatrists, will find this text of interest as it will expand their understanding of the health consequences of alcohol use disorders. In parallel, clinicians who specialize in pulmonary and/or critical care medicine will have a unique resource that provides a comprehensive review of the pathophysiology of alcohol-related lung disorders and insights into evolving therapeutic options in these vulnerable individuals. Alcohol Use Disorders and the Lung: A Clinical and Pathophysiological Approach fills a gap in the literature and presents the evolving clinical research that may soon lead to novel therapies that can improve lung health in individuals with alcohol use disorders and co-existing conditions such as HIV infection.

Respiratory Neurobiology: Physiology and Clinical Disorders, Part Two, Volume 189 is one of two volumes on the neurology of breathing. This volume focuses on pathologies attributable to abnormalities of the neural control of breathing, breathing problems that may occur in neurological diseases, and the neurological complications of respiratory diseases, while volume one focuses on the neurophysiology of breathing.

Key Features: * Covers both respiratory physiology and airway inflammation. * Highlights the use of biologic drugs. * Discusses Precision-based medicine. * Explores the co-morbidities through clinical cases.

Mitochondria, often referred to as the "powerhouses" of the cell, generate adenosine triphosphate (ATP) by oxidative phosphorylation or OXPHOS, and maintain cellular homeostasis. In addition to generating ATP, mitochondria are involved in regulation of cell cycle, proliferation, free radical production, innate immune responses and apoptosis. Mitochondrial Function in Lung Health and Disease fills the current gap in the literature and outlines the growing clinical relevance of mitochondrial dysfunction. Currently, there is no overview on the role of mitochondria in pulmonary diseases and this volume focuses on the mitochondrial metabolism, redox signaling, and mechanisms of mitochondrial pathways in lung injury, inflammation, repair and remodeling. Furthermore, in addition to their well-recognized role in cellular energy production and apoptosis, mitochondria appear to play a role in many respiratory diseases and lung cancer. Chapters are written by top notch researchers and clinicians and outline the evidence for mitochondrial biogenesis in inhalational lung injury, COPD and asthma.